# Armata Pharmaceuticals

AP-SA02, an IV phage cocktail dosed alongside standard antibiotics for complicated S. aureus bacteremia, read out positive Phase 2a data in May 2025, received FDA Qualified Infectious Disease Product designation,…


Source: https://en.bioecon.ru/companies/armata-pharmaceuticals/
Updated: 2026-08-15

- Country: United States
- Ticker: ARMP

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $28.7 million total funding from Department of Defense (DoD) award for AP-SA02 development | https://www.armatapharma.com/pipeline/ap-sa02/, https://www.sec.gov/Archives/edgar/data/921114/000110465926084861/tm2620782d2_ex99-1.htm |
| Capacity | over 10,000 full courses of phage therapy annually | https://www.sec.gov/Archives/edgar/data/921114/000110465925050219/tm2515395d1_ex99-1.htm |
| Regulatory approval | Qualified Infectious Disease Product (QIDP) and Fast Track designations for AP-SA02 | https://www.armatapharma.com/pipeline/ap-sa02/, https://www.prnewswire.com/news-releases/armata-pharmaceuticals-receives-fda-qualified-infectious-disease-product-qidp-designation-for-ap-sa02-302694147.html, https://www.sec.gov/Archives/edgar/data/921114/000110465926084861/tm2620782d2_ex99-1.htm |
| Production site | cGMP manufacturing facility in Los Angeles, California | https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-formal-commissioning-of-state-of-the-art-cgmp-phage-manufacturing-facility-in-los-angeles-california-302607412.html, https://www.sec.gov/Archives/edgar/data/921114/000110465925050219/tm2515395d1_ex99-1.htm |
| Revenue | $4.9 million in grant and award revenue for the year ended December 31, 2025 | https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-fourth-quarter-and-full-year-2025-financial-results-302725089.html, https://www.sec.gov/Archives/edgar/data/921114/000110465926034523/armp-20260325xex99d1.htm |

Independent sources: prnewswire.com, sec.gov

## Technologies

- [Bacteriophage therapy](https://en.bioecon.ru/technology/bacteriophage-therapy/)